Sulfatidosis: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Sulfatidosis | |||
| synonyms = [[Sulfatide lipidosis]], [[Metachromatic leukodystrophy]] | |||
| field = [[Neurology]], [[Genetics]] | |||
| symptoms = [[Developmental delay]], [[Muscle weakness]], [[Seizures]], [[Vision problems]], [[Hearing loss]] | |||
| complications = [[Neurological deterioration]], [[Mobility issues]], [[Cognitive impairment]] | |||
| onset = [[Infancy]] or [[early childhood]] | |||
| duration = [[Chronic]] | |||
| causes = [[Genetic mutation]] in the [[arylsulfatase A]] gene | |||
| risks = [[Family history]] of the condition | |||
| diagnosis = [[Genetic testing]], [[Enzyme assay]], [[MRI]] | |||
| differential = [[Multiple sclerosis]], [[Adrenoleukodystrophy]], [[Krabbe disease]] | |||
| treatment = [[Supportive care]], [[Physical therapy]], [[Occupational therapy]], [[Speech therapy]] | |||
| medication = [[Enzyme replacement therapy]] (experimental) | |||
| prognosis = [[Variable]], often [[progressive]] | |||
| frequency = Rare | |||
}} | |||
'''Sulfatidosis''' is a rare, inherited metabolic disorder characterized by the accumulation of sulfatides in cells, including nerve cells. There are two forms of the disorder, which are distinguished by their symptoms and genetic cause. The two forms are metachromatic leukodystrophy and multiple sulfatidosis. | '''Sulfatidosis''' is a rare, inherited metabolic disorder characterized by the accumulation of sulfatides in cells, including nerve cells. There are two forms of the disorder, which are distinguished by their symptoms and genetic cause. The two forms are metachromatic leukodystrophy and multiple sulfatidosis. | ||
== Metachromatic Leukodystrophy == | == Metachromatic Leukodystrophy == | ||
[[Metachromatic leukodystrophy]] (MLD) is characterized by the accumulation of sulfatides in cells, which causes progressive damage to cells, particularly cells in the nervous system. Symptoms of MLD can include muscle wasting and weakness, muscle rigidity, developmental delays, progressive loss of vision leading to blindness, convulsions, impaired swallowing, paralysis, and dementia. The disorder is usually fatal within a few years after symptoms appear. | [[Metachromatic leukodystrophy]] (MLD) is characterized by the accumulation of sulfatides in cells, which causes progressive damage to cells, particularly cells in the nervous system. Symptoms of MLD can include muscle wasting and weakness, muscle rigidity, developmental delays, progressive loss of vision leading to blindness, convulsions, impaired swallowing, paralysis, and dementia. The disorder is usually fatal within a few years after symptoms appear. | ||
== Multiple Sulfatidosis == | == Multiple Sulfatidosis == | ||
[[Multiple sulfatidosis]] is a disorder characterized by the accumulation of multiple types of sulfatides, leading to cell damage. Symptoms can include developmental delay, coarse facial features, short stature, bone abnormalities, and vision and hearing problems. | [[Multiple sulfatidosis]] is a disorder characterized by the accumulation of multiple types of sulfatides, leading to cell damage. Symptoms can include developmental delay, coarse facial features, short stature, bone abnormalities, and vision and hearing problems. | ||
== Causes == | == Causes == | ||
Sulfatidosis is caused by mutations in the [[ARSA]] gene (in MLD) or the [[SUMF1]] gene (in multiple sulfatidosis). These genes provide instructions for producing enzymes that break down sulfatides. When these genes are mutated, the enzymes are deficient or absent, leading to the accumulation of sulfatides in cells. | Sulfatidosis is caused by mutations in the [[ARSA]] gene (in MLD) or the [[SUMF1]] gene (in multiple sulfatidosis). These genes provide instructions for producing enzymes that break down sulfatides. When these genes are mutated, the enzymes are deficient or absent, leading to the accumulation of sulfatides in cells. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of sulfatidosis is based on clinical examination, genetic testing, and biochemical testing to measure the levels of sulfatides in the body. | Diagnosis of sulfatidosis is based on clinical examination, genetic testing, and biochemical testing to measure the levels of sulfatides in the body. | ||
== Treatment == | == Treatment == | ||
There is currently no cure for sulfatidosis. Treatment is supportive and based on the symptoms in each individual. This can include physical therapy, medication for seizures, and other supportive treatments. | There is currently no cure for sulfatidosis. Treatment is supportive and based on the symptoms in each individual. This can include physical therapy, medication for seizures, and other supportive treatments. | ||
== See also == | == See also == | ||
* [[Lysosomal storage disease]] | * [[Lysosomal storage disease]] | ||
* [[Leukodystrophy]] | * [[Leukodystrophy]] | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 00:48, 4 April 2025
| Sulfatidosis | |
|---|---|
| Synonyms | Sulfatide lipidosis, Metachromatic leukodystrophy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Developmental delay, Muscle weakness, Seizures, Vision problems, Hearing loss |
| Complications | Neurological deterioration, Mobility issues, Cognitive impairment |
| Onset | Infancy or early childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in the arylsulfatase A gene |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, Enzyme assay, MRI |
| Differential diagnosis | Multiple sclerosis, Adrenoleukodystrophy, Krabbe disease |
| Prevention | N/A |
| Treatment | Supportive care, Physical therapy, Occupational therapy, Speech therapy |
| Medication | Enzyme replacement therapy (experimental) |
| Prognosis | Variable, often progressive |
| Frequency | Rare |
| Deaths | N/A |
Sulfatidosis is a rare, inherited metabolic disorder characterized by the accumulation of sulfatides in cells, including nerve cells. There are two forms of the disorder, which are distinguished by their symptoms and genetic cause. The two forms are metachromatic leukodystrophy and multiple sulfatidosis.
Metachromatic Leukodystrophy[edit]
Metachromatic leukodystrophy (MLD) is characterized by the accumulation of sulfatides in cells, which causes progressive damage to cells, particularly cells in the nervous system. Symptoms of MLD can include muscle wasting and weakness, muscle rigidity, developmental delays, progressive loss of vision leading to blindness, convulsions, impaired swallowing, paralysis, and dementia. The disorder is usually fatal within a few years after symptoms appear.
Multiple Sulfatidosis[edit]
Multiple sulfatidosis is a disorder characterized by the accumulation of multiple types of sulfatides, leading to cell damage. Symptoms can include developmental delay, coarse facial features, short stature, bone abnormalities, and vision and hearing problems.
Causes[edit]
Sulfatidosis is caused by mutations in the ARSA gene (in MLD) or the SUMF1 gene (in multiple sulfatidosis). These genes provide instructions for producing enzymes that break down sulfatides. When these genes are mutated, the enzymes are deficient or absent, leading to the accumulation of sulfatides in cells.
Diagnosis[edit]
Diagnosis of sulfatidosis is based on clinical examination, genetic testing, and biochemical testing to measure the levels of sulfatides in the body.
Treatment[edit]
There is currently no cure for sulfatidosis. Treatment is supportive and based on the symptoms in each individual. This can include physical therapy, medication for seizures, and other supportive treatments.
See also[edit]
References[edit]
<references />


